FN1 and cancer: In summary, we demonstrated that TEPA inhibits hypoxia-induced EMT through targeting HIF1-α-Snail/Twist signaling pathway, which inhibits the EMT markers (vimentin, and fibronectin) and induces cytoskeleton remodeling, leading to the reversal of EMT, decreased invasiveness of malignant tumor, and enhanced survival.